{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:52:31Z","timestamp":1786125151274,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/3\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEUROSURGERY","NEUROS"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>The diagnosis-specific graded prognostic assessment scale (ds-GPA) for patients with melanoma brain metastasis (BM) utilizes only 2 key prognostic variables: Karnofsky performance status and the number of intracranial metastases. We wished to determine whether inclusion of cumulative intracranial tumor volume (CITV) into the ds-GPA model for melanoma augmented its prognostic value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To determine whether or not CITV augments the ds-GPA prognostic scale for melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We analyzed the survival pattern of 344 melanoma patients with BM treated with stereotactic radiosurgery (SRS) at separate institutions and validated our findings in an independent cohort of 201 patients. The prognostic value of ds-GPA for melanoma was quantitatively compared with and without the addition of CITV using the net reclassification index (NRI\u00a0&gt;\u00a00) and integrated discrimination improvement (IDI) metrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The incorporation of CITV into the melanoma-specific ds-GPA model enhanced its prognostic accuracy. Addition of CITV to the ds-GPA model significantly improved its prognostic value, with NRI\u00a0&gt;\u00a00 of 0.366 (95% CI: 0.125-0.607,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0= .002) and IDI of 0.024 (95% CI: 0.008-0.040,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u00a0= .004). We validated these findings that CITV improves the prognostic utility of melanoma ds-GPA in an independent cohort of 201 melanoma cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>The prognostic value of the ds-GPA scale for melanoma BM is enhanced by the incorporation of CITV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyx380","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:09:50Z","timestamp":1498259390000},"page":"237-244","source":"Crossref","is-referenced-by-count":22,"title":["Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases"],"prefix":"10.1227","volume":"83","author":[{"given":"Brian R","family":"Hirshman","sequence":"first","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayard R","family":"Wilson","sequence":"additional","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir Amaan","family":"Ali","sequence":"additional","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Schupper","sequence":"additional","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Proudfoot","sequence":"additional","affiliation":[{"name":"Clinical and Translational Research Institute, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Goetsch","sequence":"additional","affiliation":[{"name":"San Diego Gamma Knife Center, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob S","family":"Carter","sequence":"additional","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Neurosurgery, Copenhagen University Hospital Rigsho-spitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Chiang","sequence":"additional","affiliation":[{"name":"Depa-rtment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Yale Cancer Center, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Fogarty","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Wollstonecraft, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hong","sequence":"additional","affiliation":[{"name":"Melanoma Institute Australia, Wollstonecraft, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark C","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Translational and Applied Neuro-Oncology, Department of Neuro-surgery, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,8]]},"reference":[{"issue":"10","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00415-002-0870-6","article-title":"Management of brain metastases","volume":"249","author":"Soffietti","year":"2002","journal-title":"J Neurol."},{"issue":"4","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","article-title":"Radiosurgery for brain metastases: a score index for predicting prognosis","volume":"46","author":"Weltman","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/B:JORA.0000010892.99686.9e","article-title":"Score index for stereotactic radiosurgery of brain metastases","volume":"1","author":"Weltman","year":"1998","journal-title":"J Radiosurg."},{"issue":"1","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2004.02.017","article-title":"Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems","volume":"60","author":"Lorenzoni","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2011","journal-title":"J Clin Oncol."},{"issue":"3","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","article-title":"Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients","volume":"77","author":"Sperduto","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"Sperduto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"Suppl","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/2012.3.GKS1289","article-title":"Validation of recursive partitioning analysis and diagnosis-specific graded prognostic assessment in patients treated initially with radiosurgery alone","volume":"117","author":"Likhacheva","year":"2012","journal-title":"J Neurosurg"},{"issue":"2","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1227\/NEU.0000000000001123","article-title":"Cumulative intracranial tumor volume (CITV) enhances the prognostic value of the lung-specific graded prognostic assessment (GPA) model","volume":"79","author":"Marcus","year":"2016","journal-title":"Neurosurgery."},{"issue":"6","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ejca.2014.01.001","article-title":"Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration","volume":"50","author":"Gonda","year":"2014","journal-title":"Eur J Cancer."},{"issue":"3","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2012.05.047","article-title":"Predictors of survival in contemporary practice after initial radiosurgery for brain metastases","volume":"85","author":"Likhacheva","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"Suppl","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/2014.7.GKS14980","article-title":"A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified basic score for brain metastases","volume":"121","author":"Serizawa","year":"2014","journal-title":"J Neurosurg."},{"issue":"1","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11060-016-2084-2","article-title":"Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries","volume":"128","author":"Marshall","year":"2016","journal-title":"J Neurooncol."},{"issue":"5","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1474-4422(05)70072-7","article-title":"Therapeutic management of brain metastasis","volume":"4","author":"Kaal","year":"2005","journal-title":"Lancet Neurol."},{"issue":"9422","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(04)16250-8","article-title":"Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial","volume":"363","author":"Andrews","year":"2004","journal-title":"Lancet."},{"issue":"6","key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models","volume":"176","author":"Pencina","year":"2012","journal-title":"Am J Epidemiol."},{"issue":"4","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijrobp.2003.12.037","article-title":"Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases","volume":"59","author":"Selek","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"8","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605622","article-title":"Determinants of survival in patients with brain metastases from cutaneous melanoma","volume":"102","author":"Staudt","year":"2010","journal-title":"Br J Cancer."},{"issue":"3","key":"bib21-20231011","first-page":"656","article-title":"Stereotactic radiosurgery for patients with \u201cradioresistant\u201d brain metastase","volume":"51","author":"Brown","year":"2002","journal-title":"Neurosurgery."},{"issue":"suppl 1","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/00008390-199706001-00062","article-title":"Simultaneous chemotherapy and radiotherapy for cerebral metastases from malignant melanoma","volume":"7","author":"Ulrich","year":"1997","journal-title":"Melanoma Res."},{"issue":"5","key":"bib23-20231011","first-page":"936","article-title":"Outcome variation among \u201cradioresistant\u201d brain metastases treated with stereotactic radiosurgery","volume":"56","author":"Chang","year":"2005","journal-title":"Neurosurgery."},{"issue":"1","key":"bib24-20231011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0169-5002(02)00030-2","article-title":"Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors","volume":"37","author":"Zabel","year":"2002","journal-title":"Lung Cancer."},{"issue":"3","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0169-5002(03)00236-8","article-title":"Three irradiation treatment options including radiosurgery for brain metastases from primary lung cancer","volume":"41","author":"Noel","year":"2003","journal-title":"Lung Cancer."},{"issue":"Suppl 1","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3171\/2016.8.GKS161359","article-title":"Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery","volume":"125","author":"Bian","year":"2016","journal-title":"J Neurosurg."},{"issue":"3","key":"bib27-20231011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/HJR.0b013e3283213140","article-title":"How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators","volume":"16","author":"Cooney","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"issue":"2","key":"bib28-20231011","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin."},{"issue":"13","key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9","article-title":"Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival","volume":"19","author":"Cronin","year":"2000","journal-title":"Stat Med."}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/83\/2\/237\/32599553\/nyx380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201808000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:50:58Z","timestamp":1786121458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201808000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyx380","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}